A novel androgen-dependent prostate cancer xenograft model derived from skin metastasis of a Japanese patient

Prostate

Volumn 69, Issue 15, 2009, Pages 1660-1667

  Kimura, Takahiro ^a   Kiyota, Hiroshi ^a   Nakata, Daisuke ^b   Masaki, Tsuneo ^b   Kusaka, Masami ^b   Egawa, Shin ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Androgen dependence; Prostate cancer; Xenograft

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; DIETHYLSTILBESTROL; ESTRADIOL; FLUTAMIDE; HYDROCORTISONE; LEUPRORELIN; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TUMOR ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PATIENT; CANCER TISSUE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; HORMONE DEPENDENCE; HORMONE SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SKIN METASTASIS; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR XENOGRAFT; WILD TYPE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, HORMONAL; ASIAN CONTINENTAL ANCESTRY GROUP; DIETHYLSTILBESTROL; HUMANS; LEUPROLIDE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SKIN NEOPLASMS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 70349515823     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21016     Document Type: Article

References (28)

1. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003;30(2):209-217.
2. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005;41(6):834-845. (Pubitemid 40467547)
3. Watanabe M, Nakayama T, Shiraishi T, Stemmermann GN, Yatani R. Comparative studies of prostate cancer in Japan versus the United States. A review. Urol Oncol 2000;5(6):274-283.
4. van Weerden WM, Romijn JC. Use of nude mouse xenograft models in prostate cancer research. Prostate 2000;43(4):263-271. (Pubitemid 30367961)
5. Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Characterization of a novel androgensensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res 1996;2(6):1039-1048. (Pubitemid 26198473)
6. Denmeade SR, Sokoll LJ, Chan DW, Khan SR, Isaacs JT. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. Prostate 2001;48(1):1-6.
7. Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, deVere White RW, Pretlow TG, Harris SE, Wilson EM, Mohler JL, French FS. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol 1997;11(4):450-459.
8. Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, Trapman J, Brinkmann AO, Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 1990;173(2):534-540.
9. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR Jr, Weinmann R, Einspahr HM. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 2001;98(9):4904-4909.
10. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Endocrinology 1995;136(3):1040- 1048.
11. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3(4):402-408. (Pubitemid 27145681)
12. Macintosh CA, Stower M, Reid N, Maitland NJ. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 1998;58(1):23-28. (Pubitemid 28027710)
13. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, Cheng L. Independent origin of multiple foci of prostatic intraepithelial neoplasia: Comparison with matched foci of prostate carcinoma. Cancer 1998;83(9):1995-2002. (Pubitemid 28503732)
14. Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G. The human PC346 xenograft and cell line panel:Amodel system for prostate cancer progression. Eur Urol 2006;49(2):245-257. (Pubitemid 43197860)
15. Huggins C, Hodges CV. Studies of prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232-240.
16. Paulson DF. Management of metastatic prostatic cancer. Urology 1985;25 (2 Suppl):49-52.
17. Brehmer B, Marquardt H, Madsen PO. Growth and hormonal response of cells derived from carcinoma and hyperplasia of the prostate in monolayer cell culture. A possible in vitro model for clinical chemotherapy. J Urol 1972;108(6):890-896.
18. Robertson CN, Roberson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS, Fine RL. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 1996;88(13):908-917. (Pubitemid 26230642)
19. Sugimura Y, Cunha GR, Yonemura CU, Kawamura J. Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia of the developing human prostate. Hum Pathol 1988;19(2):133-139. (Pubitemid 18091018)
20. Levine AC, Kirschenbaum A, Droller M, Gabrilove JL. Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. J Urol 1991;146(3):790-793.
21. Noble RL. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. Cancer Res 1980;40(10):3547-3550. (Pubitemid 10003747)
22. Bosland MC, Ford H, Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 1995;16(6):1311-1317.
23. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93(12):5925-5930. (Pubitemid 26190778)
24. Chang WY, Prins GS. Estrogen receptor-beta: Implications for the prostate gland. Prostate 1999;40(2):115-124.
25. Lau KM, LaSpina M, Long J, Ho SM. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000;60(12):3175-3182. (Pubitemid 30407914)
26. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310(5748):644-648. (Pubitemid 41528150)
27. Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 2006;66(7):3396-3400.
28. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 2008;68(1):73-80.